Back to series
#ESC2021 Hotline: PRONOUNCE: comparing cardiovascular safety of degarelix vs. leuprolide in patients with advanced prostate cancer and cardiovascular disease
MedShr Editor

#ESC2021 Hotline: PRONOUNCE: comparing cardiovascular safety of degarelix vs. leuprolide in patients with advanced prostate cancer and cardiovascular disease

MedShr Editor
Expected completion time: 15 mins
0.25 CPD Credit

#ESC2021 Hotline Presentation

Sign up to start learning
,